High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients
<p>Abstract</p> <p>Background</p> <p>Metabolic acidosis leads to chronic kidney disease (CKD) progression. The guidelines recommend a lower limit of serum bicarbonate level, but no upper limit. For serum bicarbonate level to be clinically useful as a therapeutic target...
Main Authors: | Kanda Eiichiro, Ai Masumi, Yoshida Masayuki, Kuriyama Renjiro, Shiigai Tatsuo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-01-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2369/14/4 |
Similar Items
-
Oral Bicarbonate Therapy in Non-Haemodialysis Dependent Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
by: May Khei Hu, et al.
Published: (2019-02-01) -
Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients
by: Kanda Eiichiro, et al.
Published: (2012-09-01) -
Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study
by: Navdeep Tangri, et al.
Published: (2021-05-01) -
PATTERNS OF CHRONIC KIDNEY DISEASE – MINERAL BONE DISEASE AND ITS RELATIONSHIP WITH SOCIO-DEMOGRAPHIC FACTORS AMONG THE PATIENTS OF CHRONIC KIDNEY DISEASE UNDERGOING HEMODIALYSIS
by: Batool Butt, et al.
Published: (2021-01-01) -
Serum magnesium, mortality and disease progression in chronic kidney disease
by: Rami Azem, et al.
Published: (2020-02-01)